Our study demonstrated that CREB1 and MAPK1 act through different approaches to promote MITF-mediated GC progression, with one enhancing MITF transcriptional expression and the other promoting phosphorylation of MITF proteins. The gene discussed is MAPK1; the disease is gastric cancer.